ATA Nexus 2027: Telehealth Conference Marketing Guide

What ATA Nexus Is — and Why 2027 Matters for Telehealth Vendors

The American Telemedicine Association is the trade association that has, for three decades, advocated for and built the operational and policy infrastructure of U.S. virtual care. ATA Nexus is its flagship annual meeting, and it is where the operating leaders of telemedicine, remote patient monitoring, hospital-at-home, digital therapeutics, virtual specialty care, and the payer and policy ecosystem around them come together each spring. No other U.S. meeting concentrates this many active virtual-care decision-makers in a single hall.

Nexus 2027 follows a particularly important year for the industry. The 2025-2026 stretch reset reimbursement parity rules for several telehealth services, sharpened payer scrutiny of RPM utilization, accelerated hospital-at-home program build-outs under the federal waiver framework, and pushed AI-assisted virtual care from pilot to production at large IDNs. ATA Nexus 2027 will be the meeting where those operating leaders compare notes on what scaled and what stalled — which makes the floor unusually receptive to vendors who can show real implementations, economic impact, and workflow fit rather than another platform-features deck.

The audience is small but extraordinarily concentrated. Roughly 2,000 attendees, dominated by health system virtual care leadership, RPM operators, hospital-at-home program directors, payer and policy stakeholders, DTC telehealth executives, behavioral health virtual care leaders, and a strong investor and founder cohort. Layer in the influence each attendee carries inside their organization — virtual care decisions are typically centralized in the hands of a small leadership team — and the effective buyer density is higher than the headcount suggests. For vendors selling into virtual care infrastructure, this is the meeting where commercial relationships start.

ATA Nexus 2027: What We Know and What to Plan For

• Expected dates: May 2027 (official 2027 dates not yet announced by ATA — confirm at ata-nexus.org)
• Recent precedent: Nexus 2026 ran May 12-14, 2026 at the Hyatt Regency Grand Cypress, Orlando, FL
• Meeting: ATA Nexus 2027 (31st Annual American Telemedicine Association Conference)
• Audience: Telemedicine medical directors, virtual care program leaders, chief digital health officers, RPM and home-hospital operators, behavioral health virtual care, payer and policy leaders, DTC telehealth executives, FQHC and rural health system leaders, investors and founders
• Attendance: ~2,000; heavily weighted toward operational and commercial decision-makers
• Format: Three-day compressed program with concurrent operational and policy tracks, a Telehealth Innovators Challenge, demo theater, and structured policy and payer programming
• Estimated 10x10 booth (booth fee + show services): $7,000-$14,000 based on recent Nexus pricing
• Estimated all-in cost (10x10): $30,000-$55,000 including booth build, freight, travel, four-person team
• Estimated all-in cost (premium sponsorship — demo theater, lounge, mainstage track): $80,000-$200,000+
• Cost per qualified buyer: ~$20-$35 — strong for a digital-health meeting
• Official sites: ata-nexus.org and americantelemed.org

The Nexus cost-per-attendee math looks reasonable next to broad health IT meetings like HIMSS, and the cost-per-qualified-virtual-care-decision-maker math is substantially better. A 10x10 at Nexus that puts your team in front of 80-120 active virtual care leaders across three days, with eight to twelve pre-booked meetings with named target accounts, is typically the most efficient pipeline-generation event of the year for any vendor whose buyer is a telehealth or RPM operator. The mistake is exhibiting like Nexus is a generalist health IT show. It is not. The audience is small, operational, and high-value, and the exhibit playbook needs to reflect that.

Pre-Conference Strategy: Build a Named Virtual Care Leader List

Nexus is small enough that meaningful floor time is overwhelmingly pre-booked. Virtual care medical directors and chief digital health officers do not wander the exhibit hall — they have specific operational and policy sessions to attend, specific peers to find, and a short list of vendors they have decided to evaluate against named programs already in motion. If your team plans to "see who shows up," you will leave with a stack of badge scans and minimal pipeline. Pre-show outreach is mandatory at Nexus, not optional.

Build a target list by early Q1 2027. Start with every health system, IDN, payer, and DTC platform you have ever sold into or piloted with. Layer in the top 75-100 U.S. health systems by virtual care program maturity, the major hospital-at-home programs operating under the federal waiver framework, the largest payer-owned and payer-contracted virtual care networks, and FQHC and rural health networks with active telehealth investments. Aim for a named target list of 60-120 organizations with specific people named in each one: the virtual care medical director, the chief digital health or chief telehealth officer, the RPM program lead, and the IT or CIO partner responsible for integration.

Run a five-touch outreach sequence starting eight weeks out. The cadence that consistently books pre-meetings at Nexus: a personalized email referencing the target's recent program announcement, panel appearance, or peer-reviewed publication; a LinkedIn connection request from a clinical or operations leader on your team (not a sales rep); a value-led second email with a named health-system case study or economic model; a third email offering a specific Nexus meeting slot; and a final pre-show confirmation. Our pre-conference email campaigns guide covers subject-line patterns, timing, and templates that translate cleanly to Nexus.

Leverage Nexus-aligned channels. ATA members consume a defined set of digital-health publications and analyst voices — Fierce Healthcare, Healthcare IT News, MobiHealthNews, JMIR, NEJM Catalyst, KLAS, Chilmark, and a tight circle of policy-active LinkedIn voices. Pre-show advertising and contributed content placement inside that ecosystem reaches Nexus attendees at a fraction of the cost of generalist health IT media, and with materially higher operational credibility. If you sell into virtual care and you are not visible inside the Nexus ecosystem in the eight weeks before the meeting, your booth conversations will start cold instead of warm. Pair this with broader telehealth platform marketing work and the pre-show share-of-voice math gets better.

Booth Design and Messaging for Virtual Care Operators

Nexus attendees are not a generalist health IT audience. They are operating leaders running programs that touch revenue, reimbursement, clinical quality, and patient experience simultaneously. Booth design and messaging built for HIMSS or a broad health technology meeting falls flat. Win the Nexus floor by treating the audience like the program operators they are.

Build the booth around three zones. Case study zone: named health-system, payer, or DTC implementations with concrete outcomes — adoption rates, no-show reduction, readmission impact, RPM utilization, PMPM economics, parity-eligible revenue captured. Display the customer name, the metric, the time horizon, and (where possible) a quote from the operator who ran the program. Workflow integration zone: clear visualization of how your product fits into existing EHR, eligibility, scheduling, and revenue cycle workflows. Virtual care leaders have been burned repeatedly by point solutions that did not integrate, and the question "how does this fit in Epic / Cerner / our scheduling stack" arrives within the first 60 seconds. Economic model zone: a transparent, defensible economic model — not a generic ROI calculator. Show the math by program type (RPM vs. tele-specialty vs. home-hospital vs. behavioral), by payer mix, and against the realistic baseline of the buyer's existing program.

Static graphics should answer the four questions every virtual care leader asks within 30 seconds of approaching the booth: Which named health systems or payers run this in production today? How does it integrate with our existing platform and EHR? What is the reimbursement and economic model under current policy? What is the implementation timeline and internal lift? Generic "improves patient outcomes" or "AI-powered virtual care" claims signal that you do not understand the operational reality. Specific case studies and named integrations signal that you do. Our medical conference booth design playbook covers zone layouts and signage hierarchy in more depth.

On-Site Tactics: Demo Theater, Contributed Sessions, and Operator-Level Sales

The vendors who win Nexus treat the meeting as a peer education event with embedded commercial activity, not the other way around. Virtual care leaders come for the policy and reimbursement programming, the operational case studies, the peer exchange across health systems, and the Innovators Challenge. Companies that contribute to that mission — through a contributed session, a co-presented case study with a named health-system customer, a demo theater slot, or thoughtful policy and economic content — earn floor traffic and long-term relationships. Companies that show up with consumer-grade marketing get politely walked past.

Co-presented sessions with a named health-system or payer customer are the single highest-leverage on-site tactic at Nexus. A 30-45 minute case study with a credible health-system virtual care medical director or payer leader, alongside your clinical or product lead, will fill your post-show pipeline more reliably than any other on-site investment. Operators want to hear from operators. A well-scoped Nexus contributed session — even one that lives on a secondary track rather than the mainstage — typically produces 30-60 high-quality post-show conversations on its own, often outpacing the booth in qualified pipeline contribution.

Structure your operator-level sales conversations carefully. A virtual care medical director evaluating a new telehealth platform, RPM stack, or digital therapeutic is making a multi-year decision that affects clinical quality, revenue, payer relationships, and IT roadmap. They do not want a badge scan and a generic drip. They want a structured 20-30 minute conversation with your clinical or operations lead, ideally alongside a peer reference call with a similar-scale operator already running the product. Block calendar slots in advance and protect them aggressively from interruption.

For walk-up leads, use a tiered approach. Tier 1: target-list virtual care medical directors and chief digital health officers you have been pursuing — same-day calendar invites for either an in-Nexus dinner or a structured operations call within five business days. Tier 2: high-value virtual care leaders not previously on your list — structured nurture with named case studies and economic models. Tier 3: investors, founders, fellows, and adjacent stakeholders — long-cycle nurture focused on the broader virtual care narrative your company is building. Treating all three tiers identically is the single most common Nexus follow-up mistake.

Post-Nexus Follow-Up: Converting a Two-Speed Buying Cycle

Virtual care deals close on two distinct timelines that often run in parallel. Operational tooling — RPM software, virtual care orchestration, asynchronous care tools, ambient documentation — can convert in 60-120 days when a health system already has a defined program gap and budget. Platform-level decisions and capital-tier purchases — full telehealth platform replacements, hospital-at-home technology stacks, payer-integrated RPM, AI-assisted virtual care at scale — run 9-18 months through executive sponsorship, IT review, security review, and frequently a payer or board approval. Post-Nexus follow-up needs to run both clocks in parallel without confusing them.

The most common post-Nexus mistake is treating every lead as a single timeline. A virtual care medical director who tells your team they want to evaluate your RPM stack for a specific cardiology program needs daily-cadence follow-up in the first two weeks, a security and integration call booked within 30 days, and a pilot scoped inside 60 days. A health system CIO weighing a platform consolidation needs immediate scheduling with the architecture and security teams, an economic model tailored to the system's specific payer mix and case volume, and a 12-18 month cadence aligned with capital planning. Our post-conference follow-up playbook covers the segmentation, CRM workflow, and cadence rules that hold up across both kinds of digital-health buyers.

Build a payer and policy nurture track separately from your operator pipeline. Nexus is one of the few meetings where payer medical directors, policy leaders, and health-system economics teams sit in the same hall. Vendors who build relationships across both operational and payer audiences — through joint case studies, payer-integrated economic models, and policy-aware content — compound their Nexus investment in ways that pure operator-focused vendors cannot. Most digital-health vendors under-invest in the payer side of the Nexus audience. The ones who do not earn outsized reimbursement-favorable positioning when the next parity rule, RPM utilization standard, or hospital-at-home waiver update lands.

Common Mistakes Vendors Make at ATA Nexus

Treating Nexus like HIMSS. The two meetings sit in adjacent ecosystems and share some attendee overlap, but they are operationally different. HIMSS rewards scale, breadth, and brand presence. Nexus rewards depth, specificity, and named customer evidence. A HIMSS booth airlifted into Nexus will under-perform because the audience is more operational, more skeptical of feature-led messaging, and more interested in concrete economic and workflow detail.

Leading with platform features instead of program outcomes. The Nexus audience has seen every variation of "AI-powered virtual care platform" by now. Booths that lead with feature parity, generic AI claims, or platform diagrams without named customers consistently lose floor traffic. Booths that lead with a named health system, a specific program type, a measurable outcome, and a credible economic model consistently win it.

Skipping the contributed-session or demo-theater investment. A Nexus booth alone — no matter how premium — produces a fraction of the operator-level engagement of a booth paired with a co-presented session or demo theater slot featuring a real customer. The vendors who consistently win Nexus pipeline integrate booth, session, and theater into a single content arc rather than treating them as separate sponsorship line items.

Sending the wrong rep mix. Nexus rewards clinical leaders, product leaders, and senior virtual-care-specialist sales staff over generalist territory reps. If your A-team is on a different show that week, your Nexus investment will under-perform. For a tightly defined operator meeting, who is in the booth matters more than how large the booth is.

Ignoring the policy and payer programming. Vendors who stay in the exhibit hall the entire meeting miss the operational context that shapes every buyer conversation. The policy track, payer roundtables, and reimbursement programming are where the buying environment for the next 12-18 months gets framed. Send at least one senior team member to live in those sessions and report back to the booth team in real time.

Should You Exhibit at ATA Nexus 2027?

Yes, if you sell into telehealth, RPM, hospital-at-home, digital therapeutics, virtual specialty care, or any product whose buyer is a virtual care medical director, chief digital health officer, RPM program lead, or payer virtual care leader. The categories that consistently see strong Nexus ROI include telehealth and virtual care platforms, RPM hardware and software, home-hospital and hospital-at-home technology, behavioral health virtual care, asynchronous care platforms, digital therapeutics, virtual specialty care (tele-stroke, tele-ICU, tele-derm, tele-cardiology, tele-nephrology), AI-assisted virtual care and ambient documentation, peripheral devices that integrate with telehealth workflows, and infrastructure tooling like eligibility, payer integration, and virtual care orchestration. Pair Nexus with a focused conference marketing ROI framework and the math typically clears even for first-time exhibitors — if pre-show meeting booking and post-show follow-up discipline are real.

No, if your audience is purely inpatient acute care without a virtual or remote component, or if your product is a generalist health IT category — EHR, revenue cycle, cybersecurity, infrastructure — better served by HIMSS or category-specific meetings. Nexus is a deep virtual care meeting, and floor traffic will not produce qualified pipeline for products that sit outside the digital care perimeter.

If you sell into the broader medical device or healthcare technology ecosystem with any virtual care component, Nexus 2027 still belongs on your calendar even if it is not your only show. RPM-enabled devices, peripheral diagnostics that integrate with telehealth workflows, AI-assisted documentation tools, and any device whose long-term care model is moving partially or fully to the home all have a natural buyer at Nexus. Pair it with HIMSS for category breadth and with the relevant specialty meeting (AANA, AAOS, HFMA, etc.) for clinical depth. Most virtual-care-focused vendors should treat ATA Nexus as a non-negotiable annual investment, not a discretionary one. For broader context on telehealth marketing strategy, see our telehealth device marketing guide and our medical device marketing services.